human fc Search Results


94
R&D Systems recombinant human tnf rii fc chimera
Recombinant Human Tnf Rii Fc Chimera, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human tnf rii fc chimera/product/R&D Systems
Average 94 stars, based on 1 article reviews
recombinant human tnf rii fc chimera - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

92
R&D Systems recombinant human il21r fc chimera
Recombinant Human Il21r Fc Chimera, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human il21r fc chimera/product/R&D Systems
Average 92 stars, based on 1 article reviews
recombinant human il21r fc chimera - by Bioz Stars, 2026-05
92/100 stars
  Buy from Supplier

94
R&D Systems gitr antigen
Gitr Antigen, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gitr antigen/product/R&D Systems
Average 94 stars, based on 1 article reviews
gitr antigen - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

94
R&D Systems species specific erbb3 his
Species Specific Erbb3 His, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/species specific erbb3 his/product/R&D Systems
Average 94 stars, based on 1 article reviews
species specific erbb3 his - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

90
R&D Systems mouse igg2 b anti human tigit
Mouse Igg2 B Anti Human Tigit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse igg2 b anti human tigit/product/R&D Systems
Average 90 stars, based on 1 article reviews
mouse igg2 b anti human tigit - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

94
R&D Systems human igg fc pe conjugated antibody
Human Igg Fc Pe Conjugated Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human igg fc pe conjugated antibody/product/R&D Systems
Average 94 stars, based on 1 article reviews
human igg fc pe conjugated antibody - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

90
R&D Systems recombinant actriib fc chimera
Recombinant Actriib Fc Chimera, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant actriib fc chimera/product/R&D Systems
Average 90 stars, based on 1 article reviews
recombinant actriib fc chimera - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
R&D Systems scd23 r d systems
Scd23 R D Systems, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/scd23 r d systems/product/R&D Systems
Average 90 stars, based on 1 article reviews
scd23 r d systems - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Novus Biologicals human recombinant lypd8
RT-qPCR analysis and comparison of modulation of antimicrobial factors in caput and cauda epididymidis and <t>Lypd8</t> assessment in mouse and in vitro assay. ( A ) beta-defensins, ( B ) UPEC-associated antimicrobial factors. Unpaired t test ( * ) or Mann–Whitney U test (#) for each organ, respectively, comparing sham to UPEC-infected mice ( **** P < 0.0001, *** P < 0.001, ** P < 0.01, * P < 0.05). Fold change calculated via 2 (−ddCT) method. Data presented as box-and-whisker with median and min/max. cap = caput, cau = cauda. Sham 10 days, caput n = 4, cauda n = 4; UPEC 10 days, caput n = 4, cauda n = 6. ( C ) Laser-assisted microdissection of caput epithelium and caput interstitium from wild-type epididymis, n = 2. Relative expression calculated via 2 (−dCT) method. Data presented as mean ± SD. ( D ) Bacterial adherence to MEPC5 cells under the presence (+) or absence (−) of 1 μg/ml human recombinant LYPD8 (hLYPD8). CFU/ml were calculated after incubation of agar plates at 37°C for 24 h. Summary of three independent experiments with each time n = 2–3 per group. Unpaired t test comparing the number of MEPC5-adherent UPEC in the presence or absence of LYPD8 ( **** P < 0.0001, *** P < 0.001, ** P < 0.01, * P < 0.05).
Human Recombinant Lypd8, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human recombinant lypd8/product/Novus Biologicals
Average 90 stars, based on 1 article reviews
human recombinant lypd8 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

94
R&D Systems human cd32a
RT-qPCR analysis and comparison of modulation of antimicrobial factors in caput and cauda epididymidis and <t>Lypd8</t> assessment in mouse and in vitro assay. ( A ) beta-defensins, ( B ) UPEC-associated antimicrobial factors. Unpaired t test ( * ) or Mann–Whitney U test (#) for each organ, respectively, comparing sham to UPEC-infected mice ( **** P < 0.0001, *** P < 0.001, ** P < 0.01, * P < 0.05). Fold change calculated via 2 (−ddCT) method. Data presented as box-and-whisker with median and min/max. cap = caput, cau = cauda. Sham 10 days, caput n = 4, cauda n = 4; UPEC 10 days, caput n = 4, cauda n = 6. ( C ) Laser-assisted microdissection of caput epithelium and caput interstitium from wild-type epididymis, n = 2. Relative expression calculated via 2 (−dCT) method. Data presented as mean ± SD. ( D ) Bacterial adherence to MEPC5 cells under the presence (+) or absence (−) of 1 μg/ml human recombinant LYPD8 (hLYPD8). CFU/ml were calculated after incubation of agar plates at 37°C for 24 h. Summary of three independent experiments with each time n = 2–3 per group. Unpaired t test comparing the number of MEPC5-adherent UPEC in the presence or absence of LYPD8 ( **** P < 0.0001, *** P < 0.001, ** P < 0.01, * P < 0.05).
Human Cd32a, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human cd32a/product/R&D Systems
Average 94 stars, based on 1 article reviews
human cd32a - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

94
R&D Systems psgl1 fc chimera
RT-qPCR analysis and comparison of modulation of antimicrobial factors in caput and cauda epididymidis and <t>Lypd8</t> assessment in mouse and in vitro assay. ( A ) beta-defensins, ( B ) UPEC-associated antimicrobial factors. Unpaired t test ( * ) or Mann–Whitney U test (#) for each organ, respectively, comparing sham to UPEC-infected mice ( **** P < 0.0001, *** P < 0.001, ** P < 0.01, * P < 0.05). Fold change calculated via 2 (−ddCT) method. Data presented as box-and-whisker with median and min/max. cap = caput, cau = cauda. Sham 10 days, caput n = 4, cauda n = 4; UPEC 10 days, caput n = 4, cauda n = 6. ( C ) Laser-assisted microdissection of caput epithelium and caput interstitium from wild-type epididymis, n = 2. Relative expression calculated via 2 (−dCT) method. Data presented as mean ± SD. ( D ) Bacterial adherence to MEPC5 cells under the presence (+) or absence (−) of 1 μg/ml human recombinant LYPD8 (hLYPD8). CFU/ml were calculated after incubation of agar plates at 37°C for 24 h. Summary of three independent experiments with each time n = 2–3 per group. Unpaired t test comparing the number of MEPC5-adherent UPEC in the presence or absence of LYPD8 ( **** P < 0.0001, *** P < 0.001, ** P < 0.01, * P < 0.05).
Psgl1 Fc Chimera, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/psgl1 fc chimera/product/R&D Systems
Average 94 stars, based on 1 article reviews
psgl1 fc chimera - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

93
R&D Systems nkg2dl
( A ) AML cell lines (KG1a and NB4 cells) were treated with DMSO (Ctrl), DAC (1 and 5 μM) or AZA (1 and 5 μM) for 48 hours. Soluble levels of MICA, MICB, ULBP1, ULBP2 and ULBP3 ligands were quantified by sandwich ELISA. Each bar represents the mean ± SEM of at least four independent experiments. * p < 0.05 and * p < 0.001. ( B ) KG1a and NB4 cells were treated with 5 μM of DAC for 48 hours. Before and after treatment, cell surface expression of <t>NKG2DL</t> was analyzed by flow cytometry using monoclonal antibodies specific to each NKG2DL (MICA, MICB, ULBP1, ULBP2 and ULBP3), followed by incubation with FITC-conjugated goat anti-mouse IgG. The white histograms represent the isotype control antibody and shaded grey histograms show the NKG2DL expression. Dotted vertical lines indicate mean fluorescence intensity value in untreated samples.
Nkg2dl, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nkg2dl/product/R&D Systems
Average 93 stars, based on 1 article reviews
nkg2dl - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier

Image Search Results


RT-qPCR analysis and comparison of modulation of antimicrobial factors in caput and cauda epididymidis and Lypd8 assessment in mouse and in vitro assay. ( A ) beta-defensins, ( B ) UPEC-associated antimicrobial factors. Unpaired t test ( * ) or Mann–Whitney U test (#) for each organ, respectively, comparing sham to UPEC-infected mice ( **** P < 0.0001, *** P < 0.001, ** P < 0.01, * P < 0.05). Fold change calculated via 2 (−ddCT) method. Data presented as box-and-whisker with median and min/max. cap = caput, cau = cauda. Sham 10 days, caput n = 4, cauda n = 4; UPEC 10 days, caput n = 4, cauda n = 6. ( C ) Laser-assisted microdissection of caput epithelium and caput interstitium from wild-type epididymis, n = 2. Relative expression calculated via 2 (−dCT) method. Data presented as mean ± SD. ( D ) Bacterial adherence to MEPC5 cells under the presence (+) or absence (−) of 1 μg/ml human recombinant LYPD8 (hLYPD8). CFU/ml were calculated after incubation of agar plates at 37°C for 24 h. Summary of three independent experiments with each time n = 2–3 per group. Unpaired t test comparing the number of MEPC5-adherent UPEC in the presence or absence of LYPD8 ( **** P < 0.0001, *** P < 0.001, ** P < 0.01, * P < 0.05).

Journal: Molecular Human Reproduction

Article Title: Differential tissue-specific damage caused by bacterial epididymo-orchitis in the mouse

doi: 10.1093/molehr/gaaa011

Figure Lengend Snippet: RT-qPCR analysis and comparison of modulation of antimicrobial factors in caput and cauda epididymidis and Lypd8 assessment in mouse and in vitro assay. ( A ) beta-defensins, ( B ) UPEC-associated antimicrobial factors. Unpaired t test ( * ) or Mann–Whitney U test (#) for each organ, respectively, comparing sham to UPEC-infected mice ( **** P < 0.0001, *** P < 0.001, ** P < 0.01, * P < 0.05). Fold change calculated via 2 (−ddCT) method. Data presented as box-and-whisker with median and min/max. cap = caput, cau = cauda. Sham 10 days, caput n = 4, cauda n = 4; UPEC 10 days, caput n = 4, cauda n = 6. ( C ) Laser-assisted microdissection of caput epithelium and caput interstitium from wild-type epididymis, n = 2. Relative expression calculated via 2 (−dCT) method. Data presented as mean ± SD. ( D ) Bacterial adherence to MEPC5 cells under the presence (+) or absence (−) of 1 μg/ml human recombinant LYPD8 (hLYPD8). CFU/ml were calculated after incubation of agar plates at 37°C for 24 h. Summary of three independent experiments with each time n = 2–3 per group. Unpaired t test comparing the number of MEPC5-adherent UPEC in the presence or absence of LYPD8 ( **** P < 0.0001, *** P < 0.001, ** P < 0.01, * P < 0.05).

Article Snippet: To assess the effects of LYPD8 on bacterial adherence to epididymal epithelial cells in vitro , UPEC were pre-incubated for 1 h on ice with or without 1 μg/ml human recombinant LYPD8 (product no. 9087-C4, Novus Biological, CO, USA) ( Okumura et al ., 2016 ) before infection of MEPC5 cells.

Techniques: Quantitative RT-PCR, Comparison, In Vitro, MANN-WHITNEY, Infection, Whisker Assay, Laser Capture Microdissection, Expressing, Recombinant, Incubation

( A ) AML cell lines (KG1a and NB4 cells) were treated with DMSO (Ctrl), DAC (1 and 5 μM) or AZA (1 and 5 μM) for 48 hours. Soluble levels of MICA, MICB, ULBP1, ULBP2 and ULBP3 ligands were quantified by sandwich ELISA. Each bar represents the mean ± SEM of at least four independent experiments. * p < 0.05 and * p < 0.001. ( B ) KG1a and NB4 cells were treated with 5 μM of DAC for 48 hours. Before and after treatment, cell surface expression of NKG2DL was analyzed by flow cytometry using monoclonal antibodies specific to each NKG2DL (MICA, MICB, ULBP1, ULBP2 and ULBP3), followed by incubation with FITC-conjugated goat anti-mouse IgG. The white histograms represent the isotype control antibody and shaded grey histograms show the NKG2DL expression. Dotted vertical lines indicate mean fluorescence intensity value in untreated samples.

Journal: Oncotarget

Article Title: Increasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune recognition

doi: 10.18632/oncotarget.16657

Figure Lengend Snippet: ( A ) AML cell lines (KG1a and NB4 cells) were treated with DMSO (Ctrl), DAC (1 and 5 μM) or AZA (1 and 5 μM) for 48 hours. Soluble levels of MICA, MICB, ULBP1, ULBP2 and ULBP3 ligands were quantified by sandwich ELISA. Each bar represents the mean ± SEM of at least four independent experiments. * p < 0.05 and * p < 0.001. ( B ) KG1a and NB4 cells were treated with 5 μM of DAC for 48 hours. Before and after treatment, cell surface expression of NKG2DL was analyzed by flow cytometry using monoclonal antibodies specific to each NKG2DL (MICA, MICB, ULBP1, ULBP2 and ULBP3), followed by incubation with FITC-conjugated goat anti-mouse IgG. The white histograms represent the isotype control antibody and shaded grey histograms show the NKG2DL expression. Dotted vertical lines indicate mean fluorescence intensity value in untreated samples.

Article Snippet: After blocking, 100 μl of sera or supernatant samples and recombinant human (rh) Fc chimera proteins specific for each NKG2DL (rhMICA Ref: 1300-MA, rhMICB Ref: 1599-MB, rhULBP1 Ref: 1380-UL, rhULBP2 Ref: 1298-UL,and rhULBP3 Ref: 1517-UL all from R&D Systems) were added for 2 hours at RT.

Techniques: Sandwich ELISA, Expressing, Flow Cytometry, Bioprocessing, Incubation, Control, Fluorescence

( A ) NKL cells were co-cultured with cell-free supernatants (sn) obtained from KG1a and NB4 cells untreated (sn-DMSO) or treated with 1 μM DAC for 48 hours (sn-DAC). NKL cells grow in culture medium were considered as a control (Ctrl). NKG2D expression was analyzed by flow cytometry and represented as mean fluorescence intensity (MFI). Each bar represents the mean ± SEM of three independent experiments. * versus control and p < 0.01; # versus sn-DMSO and p < 0.05. ( B ) NKL cells were co-cultured with K562 cells at the indicated E:T ratio in a cell lysis assay, in the absence (Ctrl) or presence of cellular supernatant derived from KG1a (left panel) and NB4 (middle panel) cells previously treated with DMSO (sn-DMSO) or 1 μM DAC (sn-DAC) for 48 hours. Specificity of the NKG2D-NKG2DL interaction was corroborated using an anti-NKG2D blocking mAb and the effect of DAC was assayed to analyze the non-specific effects on the lytic capacity of NKL cells (right panel). Measurements were made in duplicate and the mean ± SEM of the two independent experiments are shown. * versus control and p < 0.05; * versus control and p < 0.01; # versus sn-DMSO and p < 0.05.

Journal: Oncotarget

Article Title: Increasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune recognition

doi: 10.18632/oncotarget.16657

Figure Lengend Snippet: ( A ) NKL cells were co-cultured with cell-free supernatants (sn) obtained from KG1a and NB4 cells untreated (sn-DMSO) or treated with 1 μM DAC for 48 hours (sn-DAC). NKL cells grow in culture medium were considered as a control (Ctrl). NKG2D expression was analyzed by flow cytometry and represented as mean fluorescence intensity (MFI). Each bar represents the mean ± SEM of three independent experiments. * versus control and p < 0.01; # versus sn-DMSO and p < 0.05. ( B ) NKL cells were co-cultured with K562 cells at the indicated E:T ratio in a cell lysis assay, in the absence (Ctrl) or presence of cellular supernatant derived from KG1a (left panel) and NB4 (middle panel) cells previously treated with DMSO (sn-DMSO) or 1 μM DAC (sn-DAC) for 48 hours. Specificity of the NKG2D-NKG2DL interaction was corroborated using an anti-NKG2D blocking mAb and the effect of DAC was assayed to analyze the non-specific effects on the lytic capacity of NKL cells (right panel). Measurements were made in duplicate and the mean ± SEM of the two independent experiments are shown. * versus control and p < 0.05; * versus control and p < 0.01; # versus sn-DMSO and p < 0.05.

Article Snippet: After blocking, 100 μl of sera or supernatant samples and recombinant human (rh) Fc chimera proteins specific for each NKG2DL (rhMICA Ref: 1300-MA, rhMICB Ref: 1599-MB, rhULBP1 Ref: 1380-UL, rhULBP2 Ref: 1298-UL,and rhULBP3 Ref: 1517-UL all from R&D Systems) were added for 2 hours at RT.

Techniques: Cell Culture, Control, Expressing, Flow Cytometry, Fluorescence, Lysis, Derivative Assay, Blocking Assay

( A ) KG1a and NB4 cells were treated with inhibitors specific to ADAM17 (10 μM GW280264X) and ADAM10 (50 μM of GI254023X) for 48 hours. Levels of soluble NKG2DL (sMICA/B and sULBPs1-3) were quantified by sandwich ELISA. Values are the mean ± SEM of at least three independent experiments. * p < 0.05 and * p < 0.01. ( B ) KG1a and NB4 cells were treated with DMSO (Ctrl) or DAC (1 μM) for 48 hours. After treatment, cell surface expression of ADAM17 was analyzed by flow cytometry using anti-human ADAM17 monoclonal antibody, followed by incubation with FITC-conjugated goat anti-mouse IgG. The white histograms represent the isotype control antibody and the shaded grey histograms show the ADAM17 expression. ( C ) ADAM17 activity in KG1a and NB4 cells was measured in whole-cell lysates after treatment with DMSO (Ctrl) or DAC (5 μM) for 48 hours. Data are expressed as relative fluorescence units (RLU) at Ex/Em=490/520 nm absorbance normalized with respect to micrograms of total protein (RLU/μg). Values are the mean ± SEM of three independent experiments. * p < 0.05 and * p < 0.01.

Journal: Oncotarget

Article Title: Increasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune recognition

doi: 10.18632/oncotarget.16657

Figure Lengend Snippet: ( A ) KG1a and NB4 cells were treated with inhibitors specific to ADAM17 (10 μM GW280264X) and ADAM10 (50 μM of GI254023X) for 48 hours. Levels of soluble NKG2DL (sMICA/B and sULBPs1-3) were quantified by sandwich ELISA. Values are the mean ± SEM of at least three independent experiments. * p < 0.05 and * p < 0.01. ( B ) KG1a and NB4 cells were treated with DMSO (Ctrl) or DAC (1 μM) for 48 hours. After treatment, cell surface expression of ADAM17 was analyzed by flow cytometry using anti-human ADAM17 monoclonal antibody, followed by incubation with FITC-conjugated goat anti-mouse IgG. The white histograms represent the isotype control antibody and the shaded grey histograms show the ADAM17 expression. ( C ) ADAM17 activity in KG1a and NB4 cells was measured in whole-cell lysates after treatment with DMSO (Ctrl) or DAC (5 μM) for 48 hours. Data are expressed as relative fluorescence units (RLU) at Ex/Em=490/520 nm absorbance normalized with respect to micrograms of total protein (RLU/μg). Values are the mean ± SEM of three independent experiments. * p < 0.05 and * p < 0.01.

Article Snippet: After blocking, 100 μl of sera or supernatant samples and recombinant human (rh) Fc chimera proteins specific for each NKG2DL (rhMICA Ref: 1300-MA, rhMICB Ref: 1599-MB, rhULBP1 Ref: 1380-UL, rhULBP2 Ref: 1298-UL,and rhULBP3 Ref: 1517-UL all from R&D Systems) were added for 2 hours at RT.

Techniques: Sandwich ELISA, Expressing, Flow Cytometry, Incubation, Control, Activity Assay, Fluorescence

( A ) KG1a and NB4 cells were treated with DMSO (Ctrl) or DAC (0.25, 0.5 and 1 μM) for 48 hours, and TIMP3 expression was analyzed by qRT-PCR. Each bar represents the relative expression of TIMP3 normalized with respect to the reference gene (GAPDH), using the 2 −ΔCt method. MICA transcription levels in the KG1a cell line untreated (DMSO, Ctrl) or treated with DAC at different concentrations were used as a positive control. Results are summarized as the mean ± SEM of five independent experiments. * p < 0.05 and * p < 0.01. ( B ) TIMP3 protein levels were evaluated by western blot in KG1a and NB4 cells after treatment with DMSO (Ctrl) or DAC (1 μM or 5 μM) for 48 hours. * p < 0.05. ( C ) The TIMP3 methylation pattern was quantified by pyrosequencing in AML cell lines (KG1a and NB4 cells) before and after treatment with 1 μM or 5 μM DAC. Pie charts show the average percentage of methylation for the CpGs analyzed in the TIMP3 gene. ( D ) TIMP3 expression was inhibited by transfection of KG1a cells previously treated with DAC (1 μM) with a TIMP3-specific siRNA or nonspecific scramble siRNA (200 nM). * p < 0.05 ( E ) Soluble NKG2DL were quantified by sandwich ELISA after TIMP3 inhibition. Values shown are the mean ± SEM of three independent experiments. * versus control and p < 0.05; * versus control and p < 0.01 # versus nonspecific scramble siRNA and p < 0.05.

Journal: Oncotarget

Article Title: Increasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune recognition

doi: 10.18632/oncotarget.16657

Figure Lengend Snippet: ( A ) KG1a and NB4 cells were treated with DMSO (Ctrl) or DAC (0.25, 0.5 and 1 μM) for 48 hours, and TIMP3 expression was analyzed by qRT-PCR. Each bar represents the relative expression of TIMP3 normalized with respect to the reference gene (GAPDH), using the 2 −ΔCt method. MICA transcription levels in the KG1a cell line untreated (DMSO, Ctrl) or treated with DAC at different concentrations were used as a positive control. Results are summarized as the mean ± SEM of five independent experiments. * p < 0.05 and * p < 0.01. ( B ) TIMP3 protein levels were evaluated by western blot in KG1a and NB4 cells after treatment with DMSO (Ctrl) or DAC (1 μM or 5 μM) for 48 hours. * p < 0.05. ( C ) The TIMP3 methylation pattern was quantified by pyrosequencing in AML cell lines (KG1a and NB4 cells) before and after treatment with 1 μM or 5 μM DAC. Pie charts show the average percentage of methylation for the CpGs analyzed in the TIMP3 gene. ( D ) TIMP3 expression was inhibited by transfection of KG1a cells previously treated with DAC (1 μM) with a TIMP3-specific siRNA or nonspecific scramble siRNA (200 nM). * p < 0.05 ( E ) Soluble NKG2DL were quantified by sandwich ELISA after TIMP3 inhibition. Values shown are the mean ± SEM of three independent experiments. * versus control and p < 0.05; * versus control and p < 0.01 # versus nonspecific scramble siRNA and p < 0.05.

Article Snippet: After blocking, 100 μl of sera or supernatant samples and recombinant human (rh) Fc chimera proteins specific for each NKG2DL (rhMICA Ref: 1300-MA, rhMICB Ref: 1599-MB, rhULBP1 Ref: 1380-UL, rhULBP2 Ref: 1298-UL,and rhULBP3 Ref: 1517-UL all from R&D Systems) were added for 2 hours at RT.

Techniques: Expressing, Quantitative RT-PCR, Positive Control, Western Blot, Methylation, Transfection, Sandwich ELISA, Inhibition, Control

( A ) Soluble NKG2DL were quantified by sandwich ELISA in sera from twelve AML patients before and after Vidaza ® treatment. Lines represent the levels of each sNKG2DL (ng/mL) before and after treatment of each individual AML patient. ( B ) Expression of NKG2DL on the cell surface of blasts from five AML patients before and after Vidaza ® treatment (left panel). The right panel shows dot plots of NKG2DL expression on the cell surface of blats from a representative patient. Numbers included in the figure quadrants indicate the percentage of positive cells for each NKG2DL.

Journal: Oncotarget

Article Title: Increasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune recognition

doi: 10.18632/oncotarget.16657

Figure Lengend Snippet: ( A ) Soluble NKG2DL were quantified by sandwich ELISA in sera from twelve AML patients before and after Vidaza ® treatment. Lines represent the levels of each sNKG2DL (ng/mL) before and after treatment of each individual AML patient. ( B ) Expression of NKG2DL on the cell surface of blasts from five AML patients before and after Vidaza ® treatment (left panel). The right panel shows dot plots of NKG2DL expression on the cell surface of blats from a representative patient. Numbers included in the figure quadrants indicate the percentage of positive cells for each NKG2DL.

Article Snippet: After blocking, 100 μl of sera or supernatant samples and recombinant human (rh) Fc chimera proteins specific for each NKG2DL (rhMICA Ref: 1300-MA, rhMICB Ref: 1599-MB, rhULBP1 Ref: 1380-UL, rhULBP2 Ref: 1298-UL,and rhULBP3 Ref: 1517-UL all from R&D Systems) were added for 2 hours at RT.

Techniques: Sandwich ELISA, Expressing